News

Roche Welcomes Nina Schwab-Hautzinger to Executive Team

Roche Welcomes Nina Schwab-Hautzinger to Executive Team

Roche Announces New Head of Group Communications

In a significant development, Roche has appointed Nina Schwab-Hautzinger as the new Head of Group Communications, effective from February 1, 2026. This announcement comes as Roche continues to strengthen its leadership team to navigate the complexities of modern communications.

Nina Schwab-Hautzinger's Background

Nina brings a wealth of experience to her new role, having previously worked at BASF as Head of Corporate Communications and Government Relations. With over 13 years at Roche earlier in her career, she has held various key positions, including Head of Corporate Brand & Communications and Head of Communications & Public Affairs for Pharma in Germany.

Her international experience also includes leading a strategic communications consultancy in Singapore, making her well-equipped to address the global challenges Roche faces.

Educational Achievements

Nina's educational credentials are impressive. She studied at the University of Mannheim in Germany and the University of Waterloo in Canada, culminating in a doctorate from the University of Zurich's Department of Communication and Media Research. This academic background supports her role in steering Roche's communication strategies.

Thoughts from Roche's CEO

Roche's CEO, Thomas Schinecker, expressed enthusiasm about Nina's return, stating, "Nina's extensive expertise and her ability to navigate diverse contexts will be pivotal in advancing our strategic ambitions. Clear and impactful communication is crucial for our success in today's rapidly changing environment.@"

Schinecker also acknowledged the contributions of Barbara Schaedler, the current Head of Group Communications, for ensuring a seamless transition. Barbara has played a crucial role in maintaining the communication flow through challenging periods.

About Roche

Founded in 1896 in Basel, Roche has established itself as a leader in the biotechnology field and in-vitro diagnostics. The company is known for its commitment to scientific excellence, focusing on discovering and creating innovative medicines and diagnostics that improve patients' lives.

Sustainability Commitment

For over 125 years, Roche has integrated sustainability into its operations. The company is dedicated to the Science Based Targets initiative and aims to achieve net zero emissions by 2045. Roche continuously strives to enhance healthcare delivery, combining strengths in Diagnostics and Pharma with robust data insights.

Global Presence

With Genentech as its wholly owned member in the U.S. and a majority shareholding in Chugai Pharmaceutical in Japan, Roche has a strong global footprint. This diversity enriches Roche's perspectives and capabilities while reinforcing its commitment to enhancing health outcomes worldwide.

Contact Roche Media Relations

For further inquiries, the Roche Global Media Relations team is available. You can reach them by phone at +41 61 688 8888 or via email at media.relations@roche.com. Additionally, key contacts include:

  • Hans Trees, PhD - Phone: +41 79 407 72 58
  • Sileia Urech - Phone: +41 79 935 81 48
  • Nathalie Altermatt - Phone: +41 79 771 05 25
  • Lorena Corfas - Phone: +41 79 568 24 95
  • Simon Goldsborough - Phone: +44 797 32 72 915
  • Karsten Kleine - Phone: +41 79 461 86 83
  • Kirti Pandey - Phone: +49 172 6367262
  • Yvette Petillon - Phone: +41 79 961 92 50
  • Dr. Rebekka Schnell - Phone: +41 79 205 27 03

Frequently Asked Questions

Who is Nina Schwab-Hautzinger?

Nina Schwab-Hautzinger is appointed as the new Head of Group Communications at Roche, effective February 1, 2026, returning after a previous tenure.

What was Nina's previous role before joining Roche?

Before rejoining Roche, Nina held the position of Head of Corporate Communications and Government Relations at BASF.

What is Roche's mission?

Roche aims to discover and develop innovative medicines and diagnostics that enhance healthcare and improve lives globally.

How does Roche address sustainability?

Roche has committed to the Science Based Targets initiative and aims for net zero emissions by 2045, integrating sustainability into its core business practices.

Where can I find more information about Roche?

For more information, visit Roche's official website at www.roche.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading